Chromosomal Abnormalities and Treatment Decisions in Chronic Lymphocytic Leukemia

The panelists, William G. Wierda, MD, PhD; Susan M. O’Brien, MD; Thomas J. Kipps, MD, PhD; Richard R. Furman, MD; and Shuo Ma, MD, PhD, emphasize the importance of detecting chromosomal abnormalities in chronic lymphocytic leukemia during all stages of treatment.